BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 26196379)

  • 1. Lack of presynaptic interaction between glucocorticoid and CB1 cannabinoid receptors in GABA- and glutamatergic terminals in the frontal cortex of laboratory rodents.
    Bitencourt RM; Alpár A; Cinquina V; Ferreira SG; Pinheiro BS; Lemos C; Ledent C; Takahashi RN; Sialana FJ; Lubec G; Cunha RA; Harkany T; Köfalvi A
    Neurochem Int; 2015 Nov; 90():72-84. PubMed ID: 26196379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of cannabinoid receptors in the regulation of neurotransmitter release in the rodent striatum: a combined immunochemical and pharmacological analysis.
    Köfalvi A; Rodrigues RJ; Ledent C; Mackie K; Vizi ES; Cunha RA; Sperlágh B
    J Neurosci; 2005 Mar; 25(11):2874-84. PubMed ID: 15772347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subcellular localization of type 1 cannabinoid receptors in the rat basal ganglia.
    Mátyás F; Yanovsky Y; Mackie K; Kelsch W; Misgeld U; Freund TF
    Neuroscience; 2006; 137(1):337-61. PubMed ID: 16289348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control of cannabinoid CB1 receptor function on glutamate axon terminals by endogenous adenosine acting at A1 receptors.
    Hoffman AF; Laaris N; Kawamura M; Masino SA; Lupica CR
    J Neurosci; 2010 Jan; 30(2):545-55. PubMed ID: 20071517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presynaptic CB(1) cannabinoid receptors control frontocortical serotonin and glutamate release--species differences.
    Ferreira SG; Teixeira FM; Garção P; Agostinho P; Ledent C; Cortes L; Mackie K; Köfalvi A
    Neurochem Int; 2012 Jul; 61(2):219-26. PubMed ID: 22609378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocannabinoids contribute to metabotropic glutamate receptor-mediated inhibition of GABA release onto hippocampal CA3 pyramidal neurons in an isolated neuron/bouton preparation.
    Inada H; Maejima T; Nakahata Y; Yamaguchi J; Nabekura J; Ishibashi H
    Neuroscience; 2010 Feb; 165(4):1377-89. PubMed ID: 19961906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presynaptic mGluRs Control the Duration of Endocannabinoid-Mediated DSI.
    Colmers PLW; Bains JS
    J Neurosci; 2018 Dec; 38(49):10444-10453. PubMed ID: 30355625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transient gain of function of cannabinoid CB
    Pedro JR; Moura LIF; Valério-Fernandes Â; Baptista FI; Gaspar JM; Pinheiro BS; Lemos C; Kaufmann FN; Morgado C; Silva-Santos CSD; Tavares I; Ferreira SG; Carvalho E; Ambrósio AF; Cunha RA; Duarte JMN; Köfalvi A
    Brain Res Bull; 2020 Aug; 161():106-115. PubMed ID: 32428627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-adrenergic receptor activation increases GABA uptake in adolescent mice frontal cortex: Modulation by cannabinoid receptor agonist WIN55,212-2.
    Martins RS; de Freitas IG; Sathler MF; Martins VPPB; Schitine CS; da Silva Sampaio L; Freitas HR; Manhães AC; Dos Santos Pereira M; de Melo Reis RA; Kubrusly RCC
    Neurochem Int; 2018 Nov; 120():182-190. PubMed ID: 30170018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabinoid CB1 receptor-mediated inhibition of noradrenaline release in guinea-pig vessels, but not in rat and mouse aorta.
    Schultheiss T; Flau K; Kathmann M; Göthert M; Schlicker E
    Naunyn Schmiedebergs Arch Pharmacol; 2005 Aug; 372(2):139-46. PubMed ID: 16195872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopaminergic modulation of endocannabinoid-mediated plasticity at GABAergic synapses in the prefrontal cortex.
    Chiu CQ; Puente N; Grandes P; Castillo PE
    J Neurosci; 2010 May; 30(21):7236-48. PubMed ID: 20505090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two distinct classes of muscarinic action on hippocampal inhibitory synapses: M2-mediated direct suppression and M1/M3-mediated indirect suppression through endocannabinoid signalling.
    Fukudome Y; Ohno-Shosaku T; Matsui M; Omori Y; Fukaya M; Tsubokawa H; Taketo MM; Watanabe M; Manabe T; Kano M
    Eur J Neurosci; 2004 May; 19(10):2682-92. PubMed ID: 15147302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The CB1 cannabinoid receptor is the major cannabinoid receptor at excitatory presynaptic sites in the hippocampus and cerebellum.
    Kawamura Y; Fukaya M; Maejima T; Yoshida T; Miura E; Watanabe M; Ohno-Shosaku T; Kano M
    J Neurosci; 2006 Mar; 26(11):2991-3001. PubMed ID: 16540577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus.
    Hájos N; Ledent C; Freund TF
    Neuroscience; 2001; 106(1):1-4. PubMed ID: 11564411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hierarchical glucocorticoid-endocannabinoid interplay regulates the activation of the nucleus accumbens by insulin.
    Pinheiro BS; Lemos C; Neutzling Kaufmann F; Marques JM; da Silva-Santos CS; Carvalho E; Mackie K; Rodrigues RJ; Cunha RA; Köfalvi A
    Brain Res Bull; 2016 Jun; 124():222-30. PubMed ID: 27208730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the effects of cannabinoids on identified synaptic connections in the caudate-putamen by paired recordings in transgenic mice.
    Freiman I; Anton A; Monyer H; Urbanski MJ; Szabo B
    J Physiol; 2006 Sep; 575(Pt 3):789-806. PubMed ID: 16825300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MAM-2201, a synthetic cannabinoid drug of abuse, suppresses the synaptic input to cerebellar Purkinje cells via activation of presynaptic CB1 receptors.
    Irie T; Kikura-Hanajiri R; Usami M; Uchiyama N; Goda Y; Sekino Y
    Neuropharmacology; 2015 Aug; 95():479-91. PubMed ID: 25747605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presynaptic adenosine A2A receptors dampen cannabinoid CB1 receptor-mediated inhibition of corticostriatal glutamatergic transmission.
    Ferreira SG; Gonçalves FQ; Marques JM; Tomé ÂR; Rodrigues RJ; Nunes-Correia I; Ledent C; Harkany T; Venance L; Cunha RA; Köfalvi A
    Br J Pharmacol; 2015 Feb; 172(4):1074-86. PubMed ID: 25296982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local administration of a cannabinoid agonist alters norepinephrine efflux in the rat frontal cortex.
    Page ME; Oropeza VC; Van Bockstaele EJ
    Neurosci Lett; 2008 Jan; 431(1):1-5. PubMed ID: 18055114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of CB1 cannabinoid receptors in the amygdala and their role in the control of GABAergic transmission.
    Katona I; Rancz EA; Acsady L; Ledent C; Mackie K; Hajos N; Freund TF
    J Neurosci; 2001 Dec; 21(23):9506-18. PubMed ID: 11717385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.